BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Detailed News
Back
Zydus Lifesciences consolidated net profit declines 0.96% in the March 2025 quarter
20-May-25   14:53 Hrs IST

Net profit of Zydus Lifesciences declined 0.96% to Rs 1170.90 crore in the quarter ended March 2025 as against Rs 1182.30 crore during the previous quarter ended March 2024. Sales rose 17.21% to Rs 6290.20 crore in the quarter ended March 2025 as against Rs 5366.40 crore during the previous quarter ended March 2024.

For the full year,net profit rose 17.26% to Rs 4525.50 crore in the year ended March 2025 as against Rs 3859.50 crore during the previous year ended March 2024. Sales rose 18.68% to Rs 22573.80 crore in the year ended March 2025 as against Rs 19021.50 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales6290.205366.40 17 22573.8019021.50 19
OPM %33.7930.38 -31.2728.31 -
PBDT2129.501752.30 22 7162.105587.20 28
PBT1891.601547.00 22 6246.304823.10 30
NP1170.901182.30 -1 4525.503859.50 17

Powered by Capital Market - Live News
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)